Latest Health News

Tag: japan-tobacco

  • BAT quits nicotine inhaler to focus on vaping

    —

    by

    admin
    in

    British American Tobacco (BAT) has quit plans to market a nicotine inhaler called Voke to focus on consumer items like e-cigarettes rather than health products. The move reins in BAT's earlier, very diversified approach to cigarette alternatives, which are being pursued by all big listed tobacco companies including Philip Morris International and Japan Tobacco International…

  • BAT quits nicotine inhaler to focus on vaping

    —

    by

    admin
    in

    British American Tobacco (BAT) has quit plans to market a nicotine inhaler called Voke to focus on consumer items like e-cigarettes rather than health products. The move reins in BAT's earlier, very diversified approach to cigarette alternatives, which are being pursued by all big listed tobacco companies including Philip Morris International and Japan Tobacco International…

  • Trump presses Democrats on Obamacare, calls for bipartisan fix

    —

    by

    admin
    in

    U.S. Republican President-elect Donald Trump on Thursday kept up his attacks on Democrats and Obamacare while calling for a bipartisan effort in Congress to come up with a healthcare alternative that would lower costs and improve care. In a series of tweets, Trump, who takes office later this month, blasted Senate Democratic Leader Charles Schumer…

  • Duck cull in France’s foie gras region to contain bird flu

    —

    by

    elegant
    in

    French authorities have started slaughtering ducks in the main foie gras-producing region to try to contain a dangerous form of bird flu. Operations to destroy birds got underway Thursday in three departments …

  • Synthetic Biologics’ C. difficile mid-stage study meets main goal

    —

    by

    creative
    in

    (Reuters) – Synthetic Biologics Inc said on Thursday its experimental product designed to reduce antibiotic-resistant infections outperformed a placebo in a mid-stage trial. The company’s oral enzyme ribaxamase met the main goal of significantly reducing Clostridium difficile infection (CDI) versus a placebo in the 412-patient study. Prolonged use of antibiotics can allow this common intestinal…